Related Experiment Video
Updated: Jun 28, 2026

07:37
Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening
Published on: May 13, 2020
Chemiluminescence thrombin aptasensor using high-activity DNAzyme as catalytic label
Tao Li1, Erkang Wang, Shaojun Dong
1Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, China.
Summary
A novel DNAzyme-based aptasensor significantly enhances chemiluminescence detection of thrombin. This breakthrough offers a 10- to 100-fold increase in sensitivity for thrombin detection compared to existing methods.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Biochemistry
Background:
- Thrombin is a key biomarker in various physiological and pathological processes.
- Accurate thrombin detection is crucial for diagnosing and monitoring diseases.
- Existing detection methods often lack sufficient sensitivity and efficiency.
Purpose of the Study:
- To develop an ultrasensitive chemiluminescence aptasensor for thrombin detection.
- To utilize a high-activity DNAzyme as a catalytic label for enhanced signal amplification.
- To improve the sensitivity of thrombin detection compared to previous analytical platforms.
Main Methods:
- Design and synthesis of a high-activity DNAzyme catalytic label.
- Development of a chemiluminescence-based aptasensor platform.
- Conjugation of the DNAzyme label to aptamers for specific thrombin recognition.
- Optimization of reaction conditions for maximal chemiluminescence signal.
Main Results:
- The developed aptasensor demonstrated ultrasensitive detection of thrombin.
- A significant improvement in detection sensitivity, ranging from 10- to 100-fold, was achieved.
- The aptasensor exhibited high specificity and stability in detection.
Conclusions:
- The novel DNAzyme-aptasensor platform offers a highly sensitive and efficient method for thrombin detection.
- This approach represents a significant advancement in chemiluminescence-based biosensing.
- The developed aptasensor holds potential for clinical diagnostics and biomedical research.

